Advisor Group’s ProShares Ultra NASDAQ Biotechnology BIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $12K | Hold |
200
| – | – | ﹤0.01% | 4212 |
|
|
2019
Q3 | $9K | Hold |
200
| – | – | ﹤0.01% | 4367 |
|
|
2019
Q2 | $10K | Hold |
200
| – | – | ﹤0.01% | 4342 |
|
|
2019
Q1 | $11K | Hold |
200
| – | – | ﹤0.01% | 4302 |
|
|
2018
Q4 | $8K | Hold |
200
| – | – | ﹤0.01% | 4288 |
|
|
2018
Q3 | $14K | Hold |
200
| – | – | ﹤0.01% | 4068 |
|
|
2018
Q2 | $11K | Hold |
200
| – | – | ﹤0.01% | 4025 |
|
|
2018
Q1 | $11K | Buy |
200
+86
| +75% | +$4.73K | ﹤0.01% | 4003 |
|
|
2017
Q4 | $6K | Buy |
114
+2
| +2% | +$105 | ﹤0.01% | 4321 |
|
|
2017
Q3 | $7K | Buy |
112
+2
| +2% | +$125 | ﹤0.01% | 4116 |
|
|
2017
Q2 | $6K | Buy |
+110
| New | +$6K | ﹤0.01% | 4151 |
|
|
2016
Q4 | – | Sell |
-243
| Closed | -$12K | – | 4485 |
|
|
2016
Q3 | $12K | Sell |
243
-175
| -42% | -$8.64K | ﹤0.01% | 3436 |
|
|
2016
Q2 | $16K | Buy |
+418
| New | +$16K | ﹤0.01% | 3196 |
|